Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monkhorst

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
The Lancet. Oncology|October 16, 2023
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 studyLi-Anne H Douma, Ferry Lalezari, Vincent van der Noort, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2021
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancerP J M Joosten, A J de Langen, V van der Noort, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 17, 2025
External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinomaMilou M F Schuurbiers, Freek A van Delft, Hendrik Koffijberg, et al.
The EMBO Journal|September 16, 2000
Activation of the beta globin locus by transcription factors and chromatin modifiersT McMorrow, A van den Wijngaard, A Wollenschlaeger, et al.
Journal of Clinical Pathology|December 12, 2019
Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancerRogier Butter, Nils A 't Hart, Gerrit K J Hooijer, et al.
Clinical Chemistry|April 12, 2021
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation DetectionDaan C L Vessies, Theodora C Linders, Mirthe Lanfermeijer, et al.
Cancer Cytopathology|October 27, 2020
Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancerBregje M Koomen, Jose van der Starre-Gaal, Judith M Vonk, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluidBerit M H van Linder, Dieta Brandsma, Els Verhoeven, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
Molecular Oncology|November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancerFranziska Böttger, Teodora Radonic, Idris Bahce, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
The Lancet. Oncology|October 16, 2023
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 studyLi-Anne H Douma, Ferry Lalezari, Vincent van der Noort, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2021
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancerP J M Joosten, A J de Langen, V van der Noort, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 17, 2025
External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinomaMilou M F Schuurbiers, Freek A van Delft, Hendrik Koffijberg, et al.
The EMBO Journal|September 16, 2000
Activation of the beta globin locus by transcription factors and chromatin modifiersT McMorrow, A van den Wijngaard, A Wollenschlaeger, et al.
Journal of Clinical Pathology|December 12, 2019
Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancerRogier Butter, Nils A 't Hart, Gerrit K J Hooijer, et al.
Clinical Chemistry|April 12, 2021
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation DetectionDaan C L Vessies, Theodora C Linders, Mirthe Lanfermeijer, et al.
Cancer Cytopathology|October 27, 2020
Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancerBregje M Koomen, Jose van der Starre-Gaal, Judith M Vonk, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluidBerit M H van Linder, Dieta Brandsma, Els Verhoeven, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
Molecular Oncology|November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancerFranziska Böttger, Teodora Radonic, Idris Bahce, et al.
Pageof 16